0      0


ORIC-944, a Potent and Selective Allosteric PRC2 Inhibitor, Mediates Antitumor Efficacy Through Distinct Mechanisms in Two Prostate Cancer Xenograft Models


‐ Jun 20, 2021 11:00pm


Speaker(s):

You must be logged in and own this session in order to post comments.